Specifically, in hepatocellular carcinoma, adenoid cystic carcinoma, pheochromocytoma, and various sarcomas, high levels of RBM39 are associated with patients’ poor overall survival; in contrast, the overexpression of RBM39 is linked to the prolonged overall survival of women affected by uterine carcinoma [127]. This evidence concerns the gene RBM39 and uterine carcinoma.